Mayne Pharma : Notification of cessation of securities - MYX

Notification of cessation of +securities

Announcement Summary

Entity name

MAYNE PHARMA GROUP LIMITED

Announcement Type

New announcement

Date of this announcement

Tuesday August 03, 2021

Details of +securities that have ceased

		Number of
ASX +security		+securities that	The +securities have	Date of
code	Security description	have ceased	ceased due to	cessation
MYXAN	PERFORMANCE RIGHTS	412,329 Lapse of conditional right to	30/07/2021

securities because the conditions have not been, or have become incapable of being, satisfied

Refer to next page for full details of the announcement

Notification of cessation of +securities

1 / 4

Notification of cessation of +securities

Part 1 - Announcement Details

1.1 Name of +Entity

MAYNE PHARMA GROUP LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2	Registered Number Type	Registration Number
ABN	76115832963
1.3	ASX issuer code
MYX

1. The announcement is New announcement
2. Date of this announcement

3/8/2021

Notification of cessation of +securities

2 / 4

Notification of cessation of +securities

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

MYXAN : PERFORMANCE RIGHTS

Unquoted +equity securities that have ceased

Number of securities that have ceased

412,329

Reason for cessation

Lapse of conditional right to securities because the conditions have not been, or have become incapable of being, satisfied

Date of cessation	Is the entity paying any consideration for the cessation?
30/7/2021	No

Any other information the entity wishes to notify to ASX about the cessation?

412,329 performance rights have lapsed pursuant to Mayne Pharma's Employee Performance Rights and Option Plan.

Notification of cessation of +securities

3 / 4

Notification of cessation of +securities

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
MYX : ORDINARY FULLY PAID	1,764,840,757

3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

	Total number of
ASX +security code and description	+securities on issue
MYXAN : PERFORMANCE RIGHTS	30,490,388
MYXAW : OPTION EXPIRING 31-MAR-2026 EX $0.3193	2,800,330
MYXAV : OPTION EXPIRING 30-SEP-2025 EX $0.3554	2,210,656
MYXAT : OPTION EXPIRING 30-SEP-2025 EX $0.3309	11,695,841

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities

4 / 4